The consistent growth
partner of choice
+ Years
In Business
Funds
In operation
+ Deals
Completed
+ Billion
Commited
Growth Debt Pioneer
Since 1998, Kreos Capital has committed in excess of €5.7bn across +750 transactions, to more than 570 pan-European and Israeli high-growth companies in the technology and healthcare sectors. Today, we invest more than €800m a year and continue to enhance our product offering and presence in the markets.
Throughout this time, Kreos Capital has been the consistent growth partner of choice, providing clarity and continuity for both management teams and equity sponsors looking for a long-term finance partners willing to share our long time goals.
Flexible, tailored
approach
At Kreos Capital, we understand that
true innovation requires adaptable and
responsive financing. With significant
financial backing from blue-chip
institutional investors, robust
infrastructure, and large, experienced
investment team, Kreos consistently
provides debt facilities that match the
ever evolving needs of high-growth
companies.
Support for
every stage
Kreos Capital has the experience and
resources to support high-growth
companies through every stage of their
growth life cycle, from entry-level
growth, mid-stage development,
through to late stage and pre-IPO / exit
funding, as well as publicly listed
growth funding.
Extensive experience and investment
history in Technology and Healthcare
Kreos Capital provides financing for companies across the wide spectrum of the
Technology and Healthcare sectors. In Technology, we have invested across fintech,
enterprise software, cybersecurity, semiconductors, digital marketing, AI and other
sub-sectors, while in Healthcare, we have backed companies in areas such as drug and
treatment development, medical products and devices, and healthcare tech.
Software
Deeptech
Fintech
Digital
Life-Science
Successful track record
Kreos Capital has built its reputation through an unwavering support for all of our portfolio companies during multiple business cycles. We rely on our close and mutually beneficial working relationships with both our equity sponsor partners and management teams, and they can rely on us to successfully navigate through every stage of the economic cycle. That is why we are widely recognised throughout the industry as the preferred choice when partners are really needed.